Product liability litigation regularly involves the highest stakes in cases of extreme complexity. Faced with such franchise-threatening matters, the world’s leading corporations trust Paul, Weiss to lead them to victory. Our superior ability to establish a winning, long-term strategy, our unique skill at breaking down and presenting complicated material, and our vaunted trial prowess make us counsel of choice in many of the most important product liability lawsuits.
Pfizer Achieves Trial Victory in Second Zoloft Birth Defects Case
- Client News
- June 11, 2015
Practices
Paul, Weiss client Pfizer achieved a major victory in the second Zoloft birth defects case to go to trial in the U.S. At the conclusion of an eight-day trial, a Philadelphia jury returned a complete defense verdict and concluded that Pfizer's warnings about the risks of Zoloft were adequate. In April, a St. Louis jury cleared Pfizer of liability in a similar matter, also tried by Paul, Weiss attorneys.
The Paul, Weiss team included, among others, litigation partner Andrew Ehrlich.